Jan van Bezu

1.2k total citations
23 papers, 959 citations indexed

About

Jan van Bezu is a scholar working on Molecular Biology, Hematology and Immunology and Allergy. According to data from OpenAlex, Jan van Bezu has authored 23 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Hematology and 5 papers in Immunology and Allergy. Recurrent topics in Jan van Bezu's work include Cell Adhesion Molecules Research (5 papers), Pregnancy and preeclampsia studies (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Jan van Bezu is often cited by papers focused on Cell Adhesion Molecules Research (5 papers), Pregnancy and preeclampsia studies (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Jan van Bezu collaborates with scholars based in Netherlands, United States and United Kingdom. Jan van Bezu's co-authors include Victor W.M. van Hinsbergh, Geerten P. van Nieuw Amerongen, Casper G. Schalkwijk, Jurjan Aman, A. B. Johan Groeneveld, Ramaswamy Krishnan, Anton Vonk Noordegraaf, James P. Butler, Darinka D. Klumpers and Marie van Dijk and has published in prestigious journals such as Circulation, Nature Genetics and PLoS ONE.

In The Last Decade

Jan van Bezu

23 papers receiving 947 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan van Bezu Netherlands	18	345	175	128	126	121	23	959
Masami Ikehata Italy	21	540 1.6×	164 0.9×	199 1.6×	204 1.6×	109 0.9×	51	1.6k
Christopher R. Neal United Kingdom	17	413 1.2×	105 0.6×	78 0.6×	128 1.0×	77 0.6×	26	1.0k
D. Seiffge Germany	14	344 1.0×	204 1.2×	154 1.2×	164 1.3×	193 1.6×	48	1.1k
Begoña Campos United States	21	508 1.5×	56 0.3×	215 1.7×	145 1.2×	103 0.9×	48	1.2k
Rajashekhar Gangaraju United States	23	669 1.9×	63 0.4×	192 1.5×	143 1.1×	132 1.1×	64	1.4k
Sara M. Camp United States	23	769 2.2×	207 1.2×	218 1.7×	329 2.6×	150 1.2×	63	1.8k
Robert Szulcek Netherlands	17	389 1.1×	105 0.6×	98 0.8×	372 3.0×	114 0.9×	34	1.0k
Maria Fragiadaki United Kingdom	15	591 1.7×	142 0.8×	222 1.7×	149 1.2×	87 0.7×	27	1.3k
Liming Milbauer United States	13	421 1.2×	139 0.8×	119 0.9×	66 0.5×	215 1.8×	25	1.0k
Maija Bry Finland	13	882 2.6×	95 0.5×	147 1.1×	157 1.2×	142 1.2×	16	1.5k

Countries citing papers authored by Jan van Bezu

Since Specialization

Citations

This map shows the geographic impact of Jan van Bezu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan van Bezu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan van Bezu more than expected).

Fields of papers citing papers by Jan van Bezu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan van Bezu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan van Bezu. The network helps show where Jan van Bezu may publish in the future.

Co-authorship network of co-authors of Jan van Bezu

This figure shows the co-authorship network connecting the top 25 collaborators of Jan van Bezu. A scholar is included among the top collaborators of Jan van Bezu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan van Bezu. Jan van Bezu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bezu, Jan van, Etto C. Eringa, Femke P. M. Hoevenaars, et al.. (2021). Depletion of Arg/Abl2 improves endothelial cell adhesion and prevents vascular leak during inflammation. Angiogenesis. 24(3). 677–693. 19 indexed citations

Korkmaz, H. Ibrahim, Jan van Bezu, Wessel N. van Wieringen, et al.. (2019). Homocysteine-induced inverse expression of tissue factor and DPP4 in endothelial cells is related to NADPH oxidase activity. Physiology International. 106(1). 29–38. 3 indexed citations

Phan, Carole, Étienne-Marie Jutant, Ly Tu, et al.. (2018). Dasatinib increases endothelial permeability leading to pleural effusion. European Respiratory Journal. 51(1). 1701096–1701096. 62 indexed citations

Phan, Carole, Étienne-Marie Jutant, Ly Tu, et al.. (2018). Dasatinib increases endothelial permeability leading to pleural effusion. Archives of Cardiovascular Diseases Supplements. 10(2). 208–208. 16 indexed citations

Reinhard, Nathalie R., Jan van Bezu, Renée X. de Menezes, et al.. (2017). A CDC42-centered signaling unit is a dominant positive regulator of endothelial integrity. Scientific Reports. 7(1). 10132–10132. 20 indexed citations

Reinhard, Nathalie R., et al.. (2017). The minor histocompatibility antigen 1 (HMHA1)/ArhGAP45 is a RacGAP and a novel regulator of endothelial integrity. Vascular Pharmacology. 101. 38–47. 10 indexed citations

Koning, Nick J., Charissa E. van den Brom, Jan van Bezu, et al.. (2016). Endothelial hyperpermeability after cardiac surgery with cardiopulmonary bypass as assessed using an in vitro bioassay for endothelial barrier function. British Journal of Anaesthesia. 116(2). 223–232. 25 indexed citations

Haasdijk, Remco, Wijnand K. den Dekker, Caroline Cheng, et al.. (2016). THSD1preserves vascular integrity and protects against intraplaque haemorrhaging in ApoE^−/−mice. Cardiovascular Research. 110(1). 129–139. 24 indexed citations

Beckers, Cora, Nebojša Nick Knežević, Mohammad Tauseef, et al.. (2015). ROCK2 primes the endothelium for vascular hyperpermeability responses by raising baseline junctional tension. Vascular Pharmacology. 70. 45–54. 33 indexed citations

10.

Szulcek, Robert, Jan van Bezu, Johannes Boonstra, Jack J. W. A. van Loon, & Geerten P. van Nieuw Amerongen. (2015). Transient Intervals of Hyper-Gravity Enhance Endothelial Barrier Integrity: Impact of Mechanical and Gravitational Forces Measured Electrically. PLoS ONE. 10(12). e0144269–e0144269. 19 indexed citations

11.

Heijden, M. van der, Geerten P. van Nieuw Amerongen, Jan van Bezu, et al.. (2011). Opposing Effects of the Angiopoietins on the Thrombin-Induced Permeability of Human Pulmonary Microvascular Endothelial Cells. PLoS ONE. 6(8). e23448–e23448. 37 indexed citations

12.

Dijk, Marie van, Jan van Bezu, Caroline Dunk, et al.. (2010). The STOX1 genotype associated with pre-eclampsia leads to a reduction of trophoblast invasion by α-T-catenin upregulation. Human Molecular Genetics. 19(13). 2658–2667. 62 indexed citations

13.

Dijk, Marie van, Jan van Bezu, Ankie Poutsma, et al.. (2010). The Pre-Eclampsia Gene STOX1 Controls a Conserved Pathway in Placenta and Brain Upregulated in Late-Onset Alzheimer's Disease. Journal of Alzheimer s Disease. 19(2). 673–679. 39 indexed citations

14.

Krishnan, Ramaswamy, Darinka D. Klumpers, Chan Y. Park, et al.. (2010). Substrate stiffening promotes endothelial monolayer disruption through enhanced physical forces. American Journal of Physiology-Cell Physiology. 300(1). C146–C154. 183 indexed citations

15.

Brouwers, Olaf, Tom Teerlink, Jan van Bezu, et al.. (2008). Methylglyoxal and Methylglyoxal‐arginine Adducts Do Not Directly Inhibit Endothelial Nitric Oxide Synthase. Annals of the New York Academy of Sciences. 1126(1). 231–234. 14 indexed citations

16.

Hughes, John M., Esther J. Kuiper, Ingeborg Klaassen, et al.. (2007). Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina. Diabetologia. 50(5). 1089–1098. 65 indexed citations

17.

Dijk, Marie van, Jan van Bezu, S Chim, et al.. (2007). Reply to “STOX1 is not imprinted and is not likely to be involved in preeclampsia”. Nature Genetics. 39(3). 280–281. 6 indexed citations

18.

Schalkwijk, Casper G., Jan van Bezu, Roel C. van der Schors, et al.. (2006). Heat‐shock protein 27 is a major methylglyoxal‐modified protein in endothelial cells. FEBS Letters. 580(6). 1565–1570. 69 indexed citations

19.

Čiapaitė, Jolita, Jan van Bezu, Gerco van Eikenhorst, et al.. (2006). Palmitate and oleate have distinct effects on the inflammatory phenotype of human endothelial cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1771(2). 147–154. 29 indexed citations

20.

Hassan, Mohamed, Henk M.W. Verheul, Anita S. Jorna, et al.. (2003). The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro. British Journal of Cancer. 89(2). 357–362. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact